BIOMAT Database Logo BIOMAT Database Logo

Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis. 2001

J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
Unitat de Neuroimmunologia Clínica, H. Universitari Vall d'Hebron, Barcelona, Spain.

Recent works claiming that primary antiphospholipid syndrome (PAPS) cannot be clinically distinguished from multiple sclerosis (MS) recommend that MS patients be screened for anticardiolipin antibodies (ACA). In this study 296 randomly selected patients with MS and clinically isolated syndromes and 51 healthy controls were analyzed; ACA, anti-beta2-glycoprotein I, or antiprothrombin was found in 6 patients. No predominance of any kind of clinical manifestations and no cardinal manifestations of PAPS were found in these patients. ACA tests should be performed only when a suspicion of PAPS is raised and atypical clinical presentation for MS is found.

UI MeSH Term Description Entries
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017153 Antibodies, Anticardiolipin Antiphospholipid antibodies found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase IMMUNOASSAY employing the purified phospholipid antigen CARDIOLIPIN. Anticardiolipin Antibodies,Anticardiolipin Autoantibodies,Anticardiolipin Autoantibody,Cardiolipin Autoantibodies,Cardiolipin Autoantibody,Anticardiolipin Antibody,Antibody, Anticardiolipin,Autoantibody, Anticardiolipin,Autoantibody, Cardiolipin

Related Publications

J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
Anticardiolipin antibodies in Japanese patients with multiple sclerosis.
September 1993, Acta neurologica Scandinavica,
J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics.
May 2002, Journal of neurology, neurosurgery, and psychiatry,
J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis.
January 2009, Multiple sclerosis (Houndmills, Basingstoke, England),
J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
Anticardiolipin antibodies are not associated with rheumatic heart disease.
January 2001, Lupus,
J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis.
January 1995, Autoimmunity,
J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
[A case of myasthenia gravis associated with multiple sclerosis and positive anticardiolipin antibodies].
May 1993, Rinsho shinkeigaku = Clinical neurology,
J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
A case of multiple sclerosis associated with rheumatoid arthritis and positive anticardiolipin antibodies.
April 2003, Annals of the rheumatic diseases,
J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
Lupoid sclerosis with raised anticardiolipin antibodies.
April 1995, The Journal of the Association of Physicians of India,
J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
Anticardiolipin antibodies in systemic sclerosis.
August 1986, Arthritis and rheumatism,
J Sastre-Garriga, and J C Reverter, and J Font, and M Tintoré, and G Espinosa, and X Montalban
Anticardiolipin antibodies in systemic sclerosis.
July 1991, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!